-
Image Credit: Alberto G. -
Recent Posts
- Book Review: ‘Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare’ by Peter Gøtzsche
- Forced to Flee: Humanitarian Disasters Leave Women at Higher Risk
- Looking for $2 Trillion
- Is Viral Load Testing for HIV a Realistic Strategy in Developing Countries?
- Vaccine Hesitancy: A Call for Papers from PLOS Currents: Outbreaks
- Drugs for the Poor, Drugs for the Rich: Why the Current R&D Model Doesn’t Deliver
Topics
Africa antimicrobial drugs antiretroviral treatment cardiovascular health child health china clinical trials developing world diarrhea environment Ghostwriting global burden of disease global health guidelines health costs health information health policy health systems HIV HIV/AIDS influenza LMICs malaria maternal and perinatal health maternal health medical literature medical students Mental Health mortality MSF neglected tropical diseases open access pharmaceutical industry Policy public health reporting research ethics sanitation sub-saharan Africa systematic reviews tobacco tuberculosis vaccine water WHO
Blog Archives
This Week in PLOS Medicine: Translational Research Standards, New Cancer Risk Model, Drug Costs & BP Outcomes, & TB
Category: PLoS Medicine Week by Week
Tagged animal experiments, ARRIVE, breast cancer, drug-resistant tuberculosis, endometrial cancer, health costs, health insurance, health systems, high blood pressure, mathematical modelling, North Korea, ovarian cancer, risk factors, TB, translational research, tuberculosis
Comments Off